A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis
Clinical trial NCT00631462 · COMPLETED
Trial details
- NCT number
- NCT00631462
- Sponsor
- TargeGen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2009-10-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.